Compare FNWD & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNWD | QSI |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.1M | 165.6M |
| IPO Year | 1996 | 2020 |
| Metric | FNWD | QSI |
|---|---|---|
| Price | $42.45 | $0.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $37.50 | $1.00 |
| AVG Volume (30 Days) | 9.2K | ★ 1.4M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | $17.40 | N/A |
| Revenue Next Year | $5.44 | $618.07 |
| P/E Ratio | $43.24 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.05 | $0.69 |
| 52 Week High | $45.90 | $3.10 |
| Indicator | FNWD | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 57.61 |
| Support Level | $42.56 | $0.70 |
| Resistance Level | $44.22 | $0.92 |
| Average True Range (ATR) | 0.68 | 0.04 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 42.55 | 83.33 |
Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.